Major Basic Protein – Function and Clinical Role
Major Basic Protein (MBP) is a cytotoxic protein found in eosinophil granules, playing a key role in allergic reactions, parasite defense, and eosinophilic inflammation.
Wissenswertes über "Major Basic Protein"
Major Basic Protein (MBP) is a cytotoxic protein found in eosinophil granules, playing a key role in allergic reactions, parasite defense, and eosinophilic inflammation.
What is Major Basic Protein?
Major Basic Protein (MBP) is a highly basic, cytotoxic protein stored predominantly in the crystalline core of eosinophil granules. It constitutes approximately 50% of the total protein content of these granules, making it the most abundant protein in eosinophilic granulocytes. Its name reflects its biochemical nature: it is strongly basic (positively charged) and structurally dominant within the granules of eosinophils.
MBP belongs to the C-type lectin family and carries a high density of positive charges, enabling it to interact with and disrupt negatively charged structures on the surfaces of cells and pathogens.
Biological Function and Mechanism of Action
Major Basic Protein fulfills several important immunological roles in the human body:
- Parasite defense: MBP can destroy the membranes of parasites, particularly helminths (worm parasites), by interacting electrostatically with their negatively charged surfaces and destabilizing their cell membranes.
- Antimicrobial activity: MBP exerts toxic effects on various bacteria, viruses, and fungi, contributing to innate immune defense.
- Immune cell activation: MBP can activate mast cells and basophils, triggering the release of histamine and other inflammatory mediators.
- Tissue damage in inflammation: When released in an uncontrolled manner, MBP can damage host tissues, which is particularly relevant in allergic and chronic inflammatory conditions.
Clinical Relevance and Associated Conditions
Allergic and Atopic Diseases
In conditions such as allergic asthma, atopic dermatitis, and allergic rhinitis, increased eosinophil activation leads to excessive MBP release. The released protein damages airway mucosa, promotes inflammatory reactions, and contributes to bronchial hyperreactivity. Elevated MBP concentrations can be detected in the sputum and tissue of patients with asthma.
Eosinophilic Disorders
In conditions such as hypereosinophilic syndrome or eosinophilic esophagitis, excessive degranulation of eosinophils and the associated MBP release cause tissue damage in multiple organs, including the heart, lungs, nervous system, and gastrointestinal tract.
Parasitic Infections
During infections with helminths such as Toxocara or Schistosoma, MBP is specifically deployed to kill the parasites. This explains the characteristic elevation of eosinophil counts (eosinophilia) seen in blood tests during worm infections.
Pregnancy
Placental cells also produce a form of MBP, known as MBP-2 or placental MBP. Its function during pregnancy is not yet fully understood, but roles in immune tolerance and placental development have been proposed.
Diagnostic Relevance
Measurement of Major Basic Protein in blood, sputum, or tissue samples can be used diagnostically to assess the extent of eosinophilic inflammation. Elevated MBP levels indicate active eosinophilic inflammatory activity and are relevant in the following clinical contexts:
- Assessment of allergic asthma severity
- Diagnosis and monitoring of eosinophilic esophagitis
- Detection of parasitic infections
- Monitoring of patients with hypereosinophilic syndrome
Therapeutic Approaches
Because MBP plays a central role in eosinophilic inflammation, several modern treatment strategies aim to reduce eosinophil activity and thereby limit MBP release:
- Corticosteroids: Inhibit eosinophil activation and degranulation, thereby reducing MBP release.
- Biologics: Monoclonal antibodies such as mepolizumab, reslizumab, and benralizumab target interleukin-5 (IL-5) or its receptor, specifically reducing eosinophil numbers and activation.
- Antiparasitic therapy: In parasitic infections, treatment targets the causative organism, which secondarily normalizes eosinophil counts and MBP levels.
References
- Gleich, G.J. et al. - The major basic protein of eosinophil granules: its role in immunity and disease. In: Journal of Allergy and Clinical Immunology, 1986.
- Rothenberg, M.E. & Hogan, S.P. - The eosinophil. In: Annual Review of Immunology, 2006; 24: 147-174.
- World Allergy Organization (WAO) - Eosinophilic Disorders: Mechanisms and Management. WAO White Book on Allergy, 2013.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryGrowth Factor Kinetics
Bioavailability Study
Histamine Tolerance Status
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Cologne list
Calorie content
Related search terms: Major Basic Protein + MBP + Major Basic Protein Eosinophil